Fevipiprant, a selective prostaglandin D(2)receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by Tc2 cells (type-2 CD8(+)lymphocytes) - Xue, L; Chen, W; Luo, J; Chizari, M; Borst, R; Kazani, S; Erpenbeck, V; Sandham, D (American Thoracic Society, 2019)